000 | 01711 a2200529 4500 | ||
---|---|---|---|
005 | 20250517042605.0 | ||
264 | 0 | _c20160427 | |
008 | 201604s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0133202 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHui, Ben B | |
245 | 0 | 0 |
_aExploring the Benefits of Molecular Testing for Gonorrhoea Antibiotic Resistance Surveillance in Remote Settings. _h[electronic resource] |
260 |
_bPloS one _c2015 |
||
300 |
_ae0133202 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aAustralia _xepidemiology |
650 | 0 | 4 | _aBacterial Typing Techniques |
650 | 0 | 4 | _aDisease Notification |
650 | 0 | 4 | _aEpidemiological Monitoring |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGonorrhea _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aNeisseria gonorrhoeae _xdrug effects |
650 | 0 | 4 | _aPenicillin Resistance |
650 | 0 | 4 |
_aPenicillins _xpharmacology |
650 | 0 | 4 | _aPopulation Groups |
650 | 0 | 4 | _aPrevalence |
700 | 1 | _aRyder, Nathan | |
700 | 1 | _aSu, Jiunn-Yih | |
700 | 1 | _aWard, James | |
700 | 1 | _aChen, Marcus Y | |
700 | 1 | _aDonovan, Basil | |
700 | 1 | _aFairley, Christopher K | |
700 | 1 | _aGuy, Rebecca J | |
700 | 1 | _aLahra, Monica M | |
700 | 1 | _aLaw, Mathew G | |
700 | 1 | _aWhiley, David M | |
700 | 1 | _aRegan, David G | |
773 | 0 |
_tPloS one _gvol. 10 _gno. 7 _gp. e0133202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0133202 _zAvailable from publisher's website |
999 |
_c25080370 _d25080370 |